Clinical Trials Browser

Lymphomatoid Papulosis × Brentuximab Vedotin × 90 days × Clear all

NCT03587844 2026-04-03

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Phase 2 Recruiting

Mycosis Fungoides, Sezary Syndrome, Lymphomatoid Papulosis